trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Cancer rates are higher in developed countries than in less developed countries

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Global health data and epidemiological studies generally demonstrate that cancer incidence rates are higher in developed or high-SDI countries, often due to risk factors associated with industrialization and longer life expectancies, though lower-income regions face rapidly shifting burdens.

The analysis

The retrieved Global Burden of Disease analyses consistently indicate that age-standardized incidence rates for major cancers are higher in high Socio-demographic Index (SDI) settings compared to less developed regions, supporting the claim while acknowledging faster growth rates in some lower-SDI areas.

Evidence for · 3
Future landscapes of women's hormone-sensitive cancers: unraveling global trends, age stratification, and regional inequities (1990-2035).
Recorded source metadata

Zhou Y, Jiang M, Wu Y, Wang J, Li X, Shen K, He T, Zhang C, Zong H, Wu R, Singla RK, Lv Q, Shen B. Future landscapes of women's hormone-sensitive cancers: unraveling global trends, age stratification, and regional inequities (1990-2035).. 2026. https://doi.org/10.3389/fendo.2026.1691889

The study shows that age-standardized incidence rates of hormone-sensitive cancers increase with higher socio-demographic index (SDI), with lower SDI countries experiencing faster-growing rates from a lower baseline.

See more details
More for · 2
Global trends in early-onset liver cancer incidence and projections to 2050 based on the global burden of disease study 2021.
Recorded source metadata

Chen Z, Zheng H, Mao Y, Zhou S, Zhang S, Xu Y, Liu Y, Zhang J, Lu X. Global trends in early-onset liver cancer incidence and projections to 2050 based on the global burden of disease study 2021.. 2026. https://doi.org/10.1007/s12672-026-04940-2

Data from the Global Burden of Disease study demonstrate that age-standardized incidence rates for early-onset liver cancer rose among women in high SDI regions.

Has the Introduction of PARP Inhibitors Alleviated the Global, Regional and National Burden of Ovarian Cancer? A Segmented Regression Analysis of the Global Burden of Disease Study, 2007-2021.
Recorded source metadata

Yang H. Has the Introduction of PARP Inhibitors Alleviated the Global, Regional and National Burden of Ovarian Cancer? A Segmented Regression Analysis of the Global Burden of Disease Study, 2007-2021.. 2026. https://doi.org/10.2147/ijwh.s574460

High-income regions exhibit higher age-standardized incidence rates for ovarian cancer, contrasting with rising absolute burdens in low and middle SDI regions.

The paper trail · every fact has a biography
first checked02 Aug 2026
judged → SUPPORTED · 7502 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt